Kinoshita H, Kashiwagi S, Nishikawa M, Watanabe C, et al. Efficacy and Safety of Subcutaneous Pertuzumab-Trastuzumab (Phesgo) in Neoadjuvant Treatment of HER2-positive Breast Cancer: Real-world Data from Japan. Anticancer Res 2026;46:293-300.
PMID: 41469132